Medical Compression Systems (MCS) is a leader in innovative, non-invasive solutions for the prevention of Deep Vein Thrombosis (DVT). The company is the first and currently the only to offer the healthcare market a new class of proven Continuous Enhanced Circulation Therapy in combination with MCS’s patented Synchronized Flow Technology (C.E.C.T.® + S.F.T.) devices, which can reduce the risk of bleeding complications, thus improving the standard health care.
The company products are cleared for market in several geographies.
Founded in 1997, MCS Medical Compression Systems (Ltd.), is an Israeli public company, traded on the Tel Aviv Stock Exchange (TASE: MDCL). MCS Inc., the company’s subsidiary, is located in the USA.
Follow this Link to TASE to see MCS share status